Feature | July 16, 2013

Latest Report Shows Rebound in Radiation Therapy Market

July 16, 2013 — The U.S. radiation therapy market appears to be rebounding after a major decline in 2009, with radiation oncology centers budgeting more money for capital equipment purchases this year compared to four years ago, according to a new study published by IMV Medical Information Division.

The average capital equipment budget per site for 2013 is 30 percent higher than the average 2009 budget, according to IMV's 2012/13 Radiation Therapy Market Summary Report. The report also found that patient volume has been relatively stable over the years. “The estimated number of courses of treatment — a measure that corresponds to patient volume — was at a level of 965,620 in 2012,” observed Lorna Young, senior director, market research at IMV. “This level of patient volume has been relatively stable over the past decade, increasing at an average annual rate of less than 1 percent.”

While the numbers of patients have been relatively consistent, improvements in radiation therapy technologies are continuing to drive capital purchases. IMV reports that managers of radiation oncology centers are budgeting for new equipment purchases that incorporate treatment technologies such as image-guided radiation therapy (IGRT), stereotactic body radiation therapy (SBRT) and rotational arc therapy, which help to deliver safe and effective radiation treatments to patients.

The research indicates that more than one-third (38 percent) of the radiation therapy sites in the survey are planning to purchase external-beam radiation therapy (EBRT) units as replacement or additional units over the next three years, including linear accelerators, CyberKnife, Gamma Knife, TomoTherapy and proton therapy units.

Nearly half (45 percent) of radiation therapy sites are planning to acquire or upgrade their oncology information systems (OIS) over the next three years, with 80 percent of the planned implementations and upgrades of systems incorporating electronic medical record (EMR) data.

“Additional drivers for purchasing activity by radiation therapy facilities are to increase the IT [information technology] capabilities of information systems and to incorporate imaging into all phases of the radiation therapy workflow, with the goal of improving the accuracy of radiation therapy treatments,” Young said. “As a result, we are seeing that the proportion of radiation therapy sites budgeting capital budgets of $2.0 million or more is expected to grow, from 13 percent in 2012 to 24 percent in 2014.”

The report describes trends in the adoption of therapeutic techniques, equipment and radioactive agents. Equipment types covered include external-beam therapy units, simulators [including computed tomography (CT), positron emission tomography/computed tomography (PET/CT), magnetic resonance imaging (MR) and X-ray simulators], treatment planning systems, IGRT, record and verify/OIS, and brachytherapy equipment. Other technologies covered include intensity-modulated radiation therapy (IMRT), inverse planning, rotational arc therapy, stereotactic radiosurgery (SRS) and prostate seed therapy. Equipment and software vendors covered in the study include Accuray, Brainlab, Elekta, GE Healthcare, Philips Healthcare, Siemens Healthcare, Toshiba America Medical Systems and Varian Medical Systems.

For more information: www.imvinfo.com

Related Content

First Hospitals Achieve Inter-System Connectivity Across Accuray Radiation Therapy Platforms
News | Radiation Therapy | January 19, 2018
Accuray Inc. announced recently that the Heidelberg University Hospital in Heidelberg, Germany, and Oscar Lambret...
RayStation Selected for New Carbon Ion Therapy Center in Japan
News | Treatment Planning | January 18, 2018
January 18, 2018 – RayStation has been chosen as the treatment planning system for a new carbon-ion therapy facility
Raysearch Receives First Order for the Raycare Oncology Information System
News | Oncology Information Management Systems (OIMS) | January 18, 2018
January 18, 2018 – Anderson Regional Cancer Center (ARCC) in Meridian, Mississippi, has placed the first order for...
Mevion Receives 510(k) Clearance for Hyperscan Pencil Beam Scanning Proton Therapy
Technology | Proton Therapy | January 04, 2018
Mevion Medical Systems has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Mevion S250i...
Study Compares Radiosurgery and Whole-Brain Radiation in Lung Cancer Patients With Multiple Brain Metastases
News | Radiation Therapy | January 03, 2018
Although targeted therapies have produced dramatic advances in the ability to control some types of advanced lung...
MEDraysintell Downgrades Proton Therapy Market Projection for 2030
News | Proton Therapy | January 02, 2018
MEDraysintell recently downgraded its projection for proton therapy rooms expected to be operational in 2030 from 1,200...
California US Oncology Network Centers Adopt Xoft Electronic Brachytherapy System for Early-Stage Non-Melanoma Skin Cancer
News | Brachytherapy Systems | January 02, 2018
iCAD Inc. announced that its Xoft Axxent Electronic Brachytherapy (eBx) System is now available at two California-based...
Blue Phantom System Used for Acceptance of First European Varian Halcyon Machine
News | Radiation Therapy | January 02, 2018
IBA (Ion Beam Applications S.A.) announced in November the acceptance and beam model validation of the first Varian...
Study Finds Link Between Breast Cancer Treatments and Cellular Aging Markers
News | Women's Health | January 02, 2018
January 2, 2018 — A new study found women who had received chemotherapy and/or...
ACR Appropriateness Criteria Adds and Revises Topics for December 2017
News | Clinical Decision Support | December 29, 2017
December 29, 2017 — Radiologists can enhance the quality and effectiveness of care with the newest release of the ACR
Overlay Init